heparin造句
(1) In ISIS-3, 4852 patients received intravenous heparin off-protocol.
(2) For tPA, intravenous heparin added to aspirin seems to provide a small additional patency benefit.
(3) All three patients received prophylaxis with subcutaneous heparin and compression stockings.
(4) All were given intravenous heparin and cardiac catheterisation was carried out at I 014 days.
(5) Conversely, because early death prevents the use of heparin altogether, mortality may be falsely high in the no-heparin groups.
(6) The use of aspirin and heparin as adjuncts to thrombolysis in the setting of acute myocardial infarction is controversial.
(7) Heparin - induced thrombocytopenia occurring after discontinuation of heparin.
(8) Heparin is the treatment of choice.
(9) Heparin is the most widely used and reliable anticoagulant.
(10) Exceptions include phenytoin, theophylline, and heparin.
(11) Conclusion Subcutaneous injection of heparin can promote wound healing.
(12) However, the significant anticoagulant properties of heparin and its potential for bleeding complications may contraindicate its use as an anti-tumor compound.
(13) The current FDA - approved labeling for heparin remains unchanged, including the recommended doses.
(14) Objective:To observe the effect of microdose heparin combined with injection of compound Danshen in treating neonatal scleredema.
(15) Heparin, a highly sulfated proteoglycan, is known to have strong anticoagulant and anti-inflammatory activities.
(16) Conclusion: Perfusion with heparin can prevent salursis depositing in urinary catheter.
(17) The heparin group showed significant improvement in lymphocyte transformation ratio and phagocytotic capacity of phagocyte, but the two groups had no significant difference on hemolytic plaque test.
(18) Conclusion Heparin could make PLT and MPV decreased, especially in UFH group.
(19) Adsorption equilibrium and kinetics of heparin are studied using strong basic anion exchange resin D 208.
(20) This practice is based largely on the belief that intravenous heparin increases coronary artery patency rates.
(21) At present, the only available data on the addition of intravenous heparin to full-dose aspirin plus thrombolysis are from non-randomised comparisons.
(22) Mortality among streptokinase-treated patients was 8.3% for those who also received intravenous heparin and 9.0% for those receiving subcutaneous heparin.
(23) Reinfarction rates did not differ significantly between aspirin alone and aspirin plus subcutaneous heparin groups.
(24) Once aspirin and thrombolysis are given, however, the additional benefit of delayed subcutaneous heparin seems limited.
(25) Sobel and Collen suggested that clinical decisions on intravenous heparin should await the outcome of unfinished trials.
(26) So it is reliable to determine erythrocyte sedimentation rate through heparin anticoagulant.
(27) Methods Erythrocyte sedimentation rate of 79 normal controls and 36 patients was determined with sodium citrate and heparin.
(28) Methods Sixteen cases of malignant veinous embolus were treated with urokinase and low dose of heparin, and the hematorrhea, recurrence and allergy were observed strictly.
(29) Objective To investigate the relationship between local compression and local hemorrhage after low molecular weight heparin(LMWH) subcutaneous injection.
(30) P - ALB , T - CHO, TG, HDL - Cho , ApoA 1, ApoB 100, GSP, D 3 and Urea levels are limited by using heparin.
1234